Naturally occurring medicinal mushroom-derived antimicrobials: A case-study using Lingzhi or Reishi Ganoderma lucidum (W. Curt.:Fr.) P. Karst. (Higher basidiomycetes)

International Journal of Medicinal Mushrooms

Volumn 14, Issue 5, 2012, Pages 481-490

  Karwa, Alka ^a   Rai, Mahendra ^a  

^a SANT GADGE BABA AMRAVATI UNIVERSITY   (India)

Author keywords

Antibiotics; Bioactive compounds; Ganoderma lucidum; Medicinal mushrooms; Metabolites

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFOTAXIME; CIPROFLOXACIN; GANODERMA LUCIDUM EXTRACT; KANAMYCIN; STREPTOMYCIN;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS CEREUS; CONTROLLED STUDY; CORIOLACEAE; FRUITING BODY; GANODERMA LUCIDUM; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIA; MICROBIAL SENSITIVITY TESTS; REISHI;

BACILLUS CEREUS; BACTERIA (MICROORGANISMS); BASIDIOMYCOTA; GANODERMA LUCIDUM; KLEBSIELLA PNEUMONIAE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84872015082     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v14.i5.60     Document Type: Article

References (106)

1. Turkoglu A, Kivrak I, Mercan N, Duru ME, Gezer K, Turkoglu H. Antioxidant and antimicrobial activities of Morchella conica Pers. Afr J Biot. 2006;5:1146-1150.
2. Wang T. Active Hexose Correlated Compound (AHCC) enhances host resistance to West Nile encephalitis. 15th International Symposium of the AHCC Research Association, July 21-22, 2009, Sapporo, Japan. Submitted for publication in the Japanese Journal of Nutrition.
3. Kim MY, Seguin P, Ahn JK, Kim JJ, Chun SC, Kim EH. Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Korea. J Agric Food Chem. 2008;56:7265-7270.
4. Barja JL, Lemos ML, Toranzo A. Purification and characterization of an antibacterial substance produced by a marine Alteromonas species. Antimicrob Agents Chemother. 1989;33:1674-1679.
5. Kisugi J, Ohye H, Kamiya H, Yamazaki M. Biopolymers from marine invertebrates. XIII. Characterization of an antibacterial protein, dolabellanin A, from the albumen gland of the sea hare, Dolabella auricularia. Chem Pharm Bull. 1992;40:1537-1539.
6. James SG, Holmstrom C, Kjelleberg S. Purification and characterization of a novel antibacterial protein from the marine bacterium D2. Appl Environ Microbiol. 1996;62:2783-2788.
7. Longeon A, Peduzzi J, Barthélemy M, Corre S, Nicolas JL, Guyot M. Purification and partial identification of novel antimicrobial protein from marine bacterium Pesudoalteromonas species strain X153. Mar Biotechnol. 2004;6:633-641.
8. Lindequist U, Niedermeyer TH, Jülich WD. The pharmacological potential of mushrooms. Evid-Based Complement Alternat Med. 2005;2(3):285-299.
9. Ishikawa NK, Kasuya MCM, Vanetti MCD. Antibacterial activity of Lentinula edodes. Brazilian J Microbiol. 2001;32(3):206-210.
10. Anke T. Basidiomycetes: a source of new bioactive secondary metabolites. Progress Industr Microbiol. 1989;27:51-66.
11. Wasser SP, Weis AL. Medicinal properties of substances occurring in higher Basidiomycete mushrooms: current perspective. Int J Med Mushr. 1999;1:31-62.
12. Rosa LE, Machado KMG, Jacob CC, Capelari M, Rosa CA, Zani CL. Screening of Brazilian Basidiomycetes for antimicrobial activity. Memórias do Instituto Oswaldo Cruz. 2003;98:967-974.
13. Ezeronye OU, Daba AS, Okwujiako IA, Onumajuru IC. Antibacterial effects of crude polysaccharide extracts from sclerotium and fruitbody (sporophore) of Pleurotus tuber-regium (Fries) Singer on some clinical isolates. Int J Mol Med Adv Sci. 2005;1:202-205.
14. Zjawiony JK. Biologically active compounds from Aphyllophorales (polypore) fungi. J Nat Prod. 2004;67:300-10.
15. Badalyan S, Innocenti G, Garibyan N. Antagonistic activity of xylotrophic mushrooms against pathogenic fungi of cereals in dual culture. Phytopathol Mediterranea. 2002;41:220-226.
16. Badalyan SM. Antiprotozoal activity and mitogenic effect of mycelium of culinary-medicinal shiitake mushroom Lentinus edodes (Berk.) Singer (Agaricomycetidae). Int J Med Mushr. 2004;6:131-138.
17. Park EJ, Ko G, Kim J, Sohn DH. Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction. Biol Pharmaceut Bull. 1997;20(4):417-420.
18. Pillai T, Nair C, Janardhanan K. Polysaccharides isolated from Ganoderma lucidum occurring in Southern parts of India, protects radiation induced damages both in vitro and in vivo. Environ Toxicol Pharmacol. 2008;26:80.
19. Bowerman S. If mushrooms see the light. Los Angeles Times. http://articles.latimes.com/2008/mar/31/health/he-eat31.2008. Retrieved 2010-03-18.
20. nd ed. Santa Cruz, CA, USA: Botanica Press, Inc. 1995.
21. Wasser SP, Weis AL. Lentinus edodes (Berk.) Singer. Haifa, Israel: Peledfus Publ. House. 1997; 95 pp.
22. rd ed. Emeryville, CA, USA: Ten Speed Press, 2000.
23. Suay I, Arenal F, Asenio FJ, Basilio A, Cabello MA, Diez MT, Garcia JB, del Val AG, Gorrochategui J, Hernandez P, Pelaez F, Vicente MF. Screening of Basidiomycetes for antimicrobial activities. Antonie van Leeuwenhoek. 2000;78:129-139.
24. Gao Y, Zhou Sh, Huang M. Antibacterial and antiviral value of the genus Ganoderma P. Karst. species (Aphyllophoromycetideae): a review. Int J Med Mushr. 2003;5(3):235-246.
25. Gao Y, Tang W, Gao H, Chan E, Lan J, Li X, Zhou S. Antimicrobial activity of the medicinal mushroom Ganoderma. Food Rev Int. 2005;21(2):211-229.
26. Smania A Jr, Delle-Monache F, Smania EFA, Cuneo RS. Antibacterial activity of steroidal compounds isolated from Ganoderma applanatum (Pers.) Pat. (Aphyllophoromycetideae) fruit body. Int J Med Mushr. 1999;1:325-330.
27. Smania EFA, Delle-Monache F, Smania Jr A, Yunes RA, Cuneo RS. Antifungal activity of sterols and triterpenes isolated from Ganoderma annulare. Fitoterapia. 2003;74:375-377.
28. Sakagami H, Aoki T. Induction of immunopotentiation activity by a protein-bound polysaccharide, PSK (Review). Anticancer Res. 1991;11:993-1000.
29. Tsukagoshi S. Krestin (PSK). Cancer Treatment Rev. 1984;11:131-155.
30. Yuan C, Meiz Z. PSK protects macrophages from lipoperoxide accumulation and foam cell formation caused by oxidatively modified low density lipoprotein. Atherosclerosis. 1996;124:171-181.
31. Ohmura Y, Matsunaga K. Protective effects of a proteinbound polysaccharide, PSK, against Candida albicans infection in syngeneic tumor-bearing mice via Th1 cell functions. Cancer Biother Radiopharm. 2003;18(5):769-780.
32. Sakagami H, Takeda M. Diverse biological activity of PSK (Krestin), a protein-bound polysaccharide from Coriolus versicolor (Fr.) Quél. In: Mushroom biology and mushroom products. Chang ST, ed. Hong Kong: Chinese University Press, 1993; p. 237-45.
33. Soo ChK, Shim MJ, Kim BK. Studies on the constituents of the higher fungi of Korea. (XI). An antibiotic component and a sterol of Coriolus sanguineus Fr. Arch Pharmac Res. 1978;1(1):33-40.
34. Takeuchi T. Antitumor antibiotics discovered and studied at the Institute of Microbial Chemistry. J Cancer Res Clin Oncol. 1995;121(9-10):505-510.
35. Ulbricht C, Weissner W, Basch E. Maitake mushroom (Grifola frondosa): systematic review by the natural standard research collaboration. J Soc Integr Oncol. 2009;7(2):66-72.
36. Kumaran RS, Kim HJ, Hur BK. Taxol promising fungal endophyte, Pestalotiopsis species isolated from Taxus cuspidata. J Biosci Bioeng. 2010;110(5):541-546.
37. Masuda Y, Murata Y, Hayashi M, Nanba H. Inhibitory effect of MD-fraction on tumor metastasis: involvement of NK cell activation and suppression of intercellular adhesion molecule (ICAM)-1 expression in lung vascular endothelial cells. Biol Pharmaceut Bull. 2008;31(6):1104-1108.
38. Fullerton SA, Samadi AA, Tortorelis DG. Induction of apoptosis in human prostatic cancer cells with betaglucan (Maitake mushroom polysaccharide). Molr Urol. 2000;4(1):7-13.
39. Lee JS, Park BC, Ko YJ. Grifola frondosa (maitake mushroom) water extract inhibits vascular endothelial growth factor-induced angiogenesis through inhibition of reactive oxygen species and extracellular signal-regulated kinase phosphorylation. J Med Food. 2008;11(4):643-651.
40. Zhuang C, Mizuno T. Biological responses from Grifola frondosa (Dicks.:Fr.) S.F. Gray-Maitake (Aphyllophoromycetideae). Int J Med Mushr. 1999;1:317-324.
41. Kodama N, Komuta K, Nanba H. Effect of maitake (Grifola frondosa) D-fraction on the activation of NK cells in cancer patients. J Med Food. 2003;6:371-377.
42. Bose SR. Antibiotics from higher fungi. Arch Mikrobiol Bd. 1953;18:349-355.
43. Ahn WS, Kim DJ, Chae GT. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murrill Kyowa, in gynecological cancer patients undergoing chemotherapy. Int J Gynecol Canc. 2004;14(4):589-594.
44. Kimura Y, Kido T, Takaku T, Sumiyoshi M, Baba K. Isolation of an anti-angiogenic substance from Agaricus blazei Murrill: its antitumor and antimetastatic actions. Canc Sci. 2004;95(9):758-764.
45. Gonzaga ML, Bezerra DP, Alves AP. In vivo growthinhibition of Sarcoma 180 by an alpha-(1→4)-glucanbeta-(1→6)-glucan-protein complex polysaccharide obtained from Agaricus blazei Murrill. J Nat Med. 2009;63(1):32-40.
46. Niu YC, Liu JC, Zhao XM, Wu XX. A low molecular weight polysaccharide isolated from Agaricus blazei suppresses tumor growth and angiogenesis in vivo. Oncol Rep. 2009;21(1):145-152.
47. Cimerman GN, Cimerman A. Pleurotus fruiting bodies contain the inhibitor of 3-hydroxy-3-methylglutarylcoenzyme A reductase-lovastatin. Experiment Mycol. 1995;19(1):1-6.
48. Zusman I, Reifen R, Livni O, Smirnoff P, Gurevich P, Sandler B. Role of apoptosis, proliferating cell nuclear antigen and p53 protein in chemically induced colon cancer in rats fed corncob fiber treated with the fungus Pleurotus ostreatus. Anticanc Res. 1997;17:2105-2113.
49. Bobek P, Galbavy S. Effect of pleuran (beta-glucan from Pleurotus ostreatus) on the antioxidant status of the organism and on dimethylhydrazine-induced precancerous lesions in rat colon. Brit J Biomed Sci. 2001;58(3):164-168.
50. Alarcón J, Aguila S. Lovastatin production by Pleurotus ostreatus: effects of the C:N ratio. Zeitschr Naturforsch. 2006;61(1-2):95-98.
51. Gerasimenya VP, Efremenkova OV, Kamzolkina OV, Bogush TA, Tolstych IV, Zenkova VA. Antimicrobial and antitoxical action of edible and medicinal mushroom Pleurotus ostreatus (Jacq.:Fr.) Kumm. extracts. Int J Med Mushr. 2002;4(2):127-132.
52. Bajaj M, Vadhera S, Brar AP, Soni GL. Role of oyster mushroom (Pleurotus florida) as hypocholesterolemic/ antiatherogenic agent. Indian J Experiment Biol. 1997;35(10):1070-1075.
53. Iwalokun BA, Usen UA, Otunba AA, Olukoya DK. Comparative phytochemical evaluation, antimicrobial and antioxidant properties of Pleurotus ostreatus. Afr J Biotechnol. 2007;6(15):1732-1739.
54. Selvi S. Antibacterial activity of Pleurotus florida and Calocybe indica against selected bacterial strains. Icfai Univ J Biotechnol. 2008;2(2):23-33.
55. Tsujinaka T, Yokota M, Kambayashi J, Ou MC, Kido Y, Mori T. Modification of septic processes by beta-glucan administration. Europ Surgic Res. 1990;22(6):340-346.
56. Takehara M, Kuida K, Mori K. Antiviral activity of virus- like particles from Lentinus edodes (Shiitake). Brief report. Arch Virol. 1979;59(3):269-274.
57. Hatvani N. Antibacterial effect of the culture fluid of Lentinus edodes mycelium grown in submerged liquid culture. Int J Antimicrob Agents. 2001;17(1):71-74.
58. Shimada S, Komamura K, Kumagai H, Sakurai H. Inhibitory activity of shiitake flavor against platelet aggregation. BioFactors. 2004;22(1-4):177-179.
59. Yang P, Liang M, Zhang Y, Shen B. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Adv Therapy. 2008;25(8):787-794.
60. Kim HW, Kim BK. Biomedicinal triterpenoids of Ganoderma lucidum (Curt.:Fr.) P. Karst. (Aphyllophoromycetidae). Int J Med Mushr. 1999;1:121-138.
61. Kandefer-Szerszen M, Kawecki Z, Salata B, Witek M. Grzyby kapeluszowe jako źródło substancji o aktywności przeciwwirusowej (Mushrooms as a source of substances with antiviral activity). Acta Mycol. 1980;16(2):215-220 (in Polish).
62. Leonhardt K, Anke T, Hillen-Maske E, Steglich W. 6-Methylpurine, 6-methyl-9-beta-D-ribofuranosylpurine, and 6-hydroxymethyl-9-beta-D-ribofuranosylpurine as antiviral metabolites of Collybia maculata (Basidiomycetes). Zeitschr Naturforsch. 1987;42(4):420-424.
63. Li D, Zhao WH, Kong BH, Ye M, Chen HR. Inhibition effects of the extract and polysaccharide in macrofungus on TMV. J Yunnan Agricult Univ. 2009;24(2):175-180.
64. Wong JH, Ng TB, Wang H, Sze SC, Zhang KY, Li Q, Lu Xiaoxu. Cordymin, an antifungal peptide from the medicinal fungus Cordyceps militaris. Phytomed. 2011;18(5):387-392.
65. Hobbs Ch. Medicinal value of Lentinus edodes (Berk) Sing. A literature review. Int J Med Mushr. 2000;2:287-302.
66. Bae EA, Kim DH, Han MJ. Effect of Lentinus edodes on the growth of intestinal lactic acid bacteria. Archives Pharmaceut Res. 1997;20:443-447.
67. Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher Basidiomycete mushrooms: a modern perspective. Crit Rev Immunol. 1999;19:65-96.
68. nd ed. Coates PM, Betz JM, Blackman MR, Cragg GM, Levine M, Mass J, White JD, eds. New York: Informa Healthcare, 2010; p. 680-690.
69. Jonathan SG, Fasidi IO. Antimicrobial activities of two Nigerian edible macrofungi-Lycoperdon pusilum Bat. ex Fr. and Lycoperdon giganteum Pers. Afr J Biomed Res. 2003;6(2):85-90.
70. Barros L, Baptista P, Estevinho LM, Ferreira IC. Effect of fruiting body maturity stage on chemical composition and antimicrobial activity of Lactarius sp. mushrooms. J Agric Food Chem. 2007;55:8766-8771.
71. Kamo T, Asanoma M, Shibata H, Hirota M. Anti-inflammatory lanostane-type triterpene acids from Piptoporus betulinus. J Nat Prod. 2003;66(8):1104-1106.
72. Zhang Y, Mills GL, Nair MG. Cyclooxygenase inhibitory and antioxidant compounds from the fruiting body of an edible mushroom, Agrocybe aegerita. Phytomed. 2003;10(5):386-390.
73. Collins RA, Ng TB. Polysaccharopeptide from Coriolus versicolor has potential for use against human immunodeficiency virus type 1 infection. Life Sci. 1997;60(25):383-387.
74. Chellal A, Lukasova E. Evidence for antibiotics in the two Algerien truffles Terfezia and Tirmania. Die Pharmazie. 1995;50(3):228-229.
75. Janakat S, Al-Fakhiri S, Sallal AK. A promising peptide antibiotic from Terfezia claveryi aqueous extract against Staphylococcus aureus in vitro. Phytother Res. 2004;18(10):810-813.
76. Janakat SM, Al-Fakhiri SM, Sallal AK. Evaluation of antibacterial activity of aqueous and methanolic extracts of the truffle Terfezia claveryi against Pseudomonas aeruginosa. Saudi Med J. 2005;26(6):952-955.
77. Gezer K, Duru ME, Kivrak I, Turkoglu A, Mercan N, Turkoglu H, Gulcan S. Free-radical scavenging capacity and antimicrobial activity of wild edible mushroom from Turkey. Afr J Biotechnol. 2006;5(20):1924-1928.
78. Aziz T, Mehmet ED, Nazime AM. Antioxidant and antimicrobial activity of Russula delica Fr. an edible wild mushroom. Eur J Anal Chem. 2007;2:64-67.
79. Fagade OE, Oyelade AA. A comparative study of the antibacterial activities of some wood decay fungi to synthetic antibiotic discs. Electronic J Environment Agricult Food Chem. 2009;8(3):184-188.
80. Lindequist U, Teuscher E, Narbe G. Neue Wirkstoffe aus Basidiomyceten. Zeitschr Phytother. 1990;11:139-149 (in German).
81. Chang ST, Miles PG. Mushrooms biology: a new discipline. Mycologist. 1995;6:64-65.
82. Mothana RAA, Jansen R, Jülich WD, Lindequist U. Ganomycin A and B, new antimicrobial farnesyl hydroquinones from the basidiomycete Ganoderma pfeifferi. J Nat Prod. 2000;63:416-418.
83. Hawksworth DL. Mushrooms: the extent of the unexplored potential. Int J Med Mushr. 2001;3:333-337.
84. Bender S, Dumitrache CN, Backhaus J, Christie G, Cross RF, Lonergan GT. A case for caution in assessing the antibiotic activity of extracts of culinary-medicinal Shiitake mushroom (Lentinus edodes (Berk.) Singer). Int J Med Mushr. 2003;5:31-35.
85. Bauer AW, Kirby M, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disc method. Am J Clin Path. 1966;45:493-496.
86. Barry AL, Craig WA, Nadler H, Reller LB, Sanders CC, Swenson JM. Methods for determining bactericidal activity of antimicrobial agents; approved guidelines. Clinical and Laboratory Standards Institute. 1999;19(18).
87. Watts JL, Shryock TR, Apley M, Bade DJ, Brown SD, Gray JT, Heine H, Hunter RP, Mevius DJ, Papich MG, Silley P, Zurenko GE. Performance standards for antimicrobial disk susceptibility tests. Clinical and Laboratory Standards Institute. 2008;28(1).
88. Andrews JM. Determination of minimum inhibitory concentration. J Antimicrob Chemother. 2001;48(Suppl S1):5-16.
89. Sivakumar R, Vetrichelvan T, Rajendra NN, Devi M, Indra Sundaramurthi K, Shankar ASK, Shanmugam S. Antibacterial activity of mushroom Osmoporus odoratus. Ind J Pharm Sci. 2006;68(4):523-524.
90. Faccin LC, Benati F, Rincão VP. Antiviral activity of aqueous and ethanol extracts and of an isolated polysaccharide from Agaricus brasiliensis against poliovirus type 1. Lett Appl Microbiol. 2007;45(1):24-28.
91. Sorimachi K, Ikehara Y, Maezato G. Inhibition by Agaricus blazei Murrill fractions of cytopathic effect induced by western equine encephalitis (WEE) virus on VERO cells in vitro. Biosci Biotechnol Biochem. 2001;65(7):1645-1647.
92. Sun H, Zhao CG, Tong X, Qi YP. A lectin with mycelia differentiation and antiphytovirus activities from the edible mushroom Agrocybe aegerita. J Biochem Mol Biol. 2003;36(2):214-22.
93. Obuchi T, Kondoh H, Watanabe N, Tamai M, Omura S, Yang JS. Armillaric acid, a new antibiotic produced by Armillaria mellea. Planta Med. 1990;56(2):198-201.
94. Zheng S, Li C, Ng TB, Wang HX. A lectin with mitogenic activity from the edible wild mushroom Boletus edulis. Process Biochem. 2007;42(12):1620-1624.
95. Cieniecka-Rosłonkiewicz A, Sas A, Przybysz E, Morytz B, Syguda A, Pernak J. Ionic liquids for the production of insecticidal and microbicidal extracts of the fungus Cantharellus cibarius. Chem Biodivers. 2007;4(9):2218-2224.
96. Wang H, Ng TB. Isolation and characterization of velutin, a novel low-molecular-weight ribosome-inactivating protein from winter mushroom (Flammulina velutipes) fruiting bodies. Life Sci. 2001;68(18):2151-2158.
97. Moradali MF, Mostafavi H, Hejaroude GA, Tehrani AS, Abbasi M, Ghods S. Investigation of potential antibacterial properties of methanol extracts from fungus Ganoderma applanatum. Chemother. 2006;52(5):241-244.
98. Baldauf SL, Palmer JD. Animals and fungi are each other's closest relatives: congruent evidence from multiple proteins. Proc Natl Acad Sci U S A. 1993;90 (24):11558-11562.
99. Lee SS, Lee PL, Chen CF, Wang SY, Chen KY. Antitumor effects of polysaccharides of Ganoderma lucidum (Curt.:Fr.) P. Karst. (Ling Zhi, Reishi Mushroom) (Aphyllophoromycetidae). Int J Med Mushr. 2003;5:1-16.
100. Chen S, Oh SR, Phung S, Hur G, Ye JJ, Kwok SL, Shrode GE, Belury M. Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus). Cancer Res. 2006;66(24):12026-1234.
101. Mizuno T. Medicinal effects and utilization of Cordyceps (Fr.) Link (Ascomycetes) and Isaria Fr. (mitosporic fungi) Chinese caterpillar fungi, "Tochukaso" (review). Int J Med Mushr. 1999;1:251-261.
102. Rougieux R. Actions antibiotiques et stimulantes de la truffe du desert (Terfezia boudieri Chatin) [Antibiotic and stimulating actions of the desert truffle (Terfezia boudieri Chatin)]. Ann Inst Pasteur (Paris). 1963;105:315-318.
103. Reed RW, Holder MA. The antibacterial spectrum of ustilagic acid. Can J Med Sci. 1953;31(6):505-511.
104. Teichmann B, Liu L, Schink KO, Bölker M. Activation of the ustilagic acid biosynthesis gene cluster in Ustilago maydis by the C2H2 zinc finger transcription factor Rua1. Appl Environ Microbiol. 2010;76(8):2633-2640.
105. Grube BJ, Eng ET, Kao YC, Kwon A, Chen S. White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. J Nutrit. 2001;131(12):3288-3293.
106. Grube BJ, Eng ET, Kao YC, Kwon A, Chen S. White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. J Nutrit. 2001;131(12):3288-3293.